179 related articles for article (PubMed ID: 12007944)
1. Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time.
Lee AW; Kwong DL; Leung SF; Tung SY; Sze WM; Sham JS; Teo PM; Leung TW; Wu PM; Chappell R; Peters LJ; Fowler JF
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):75-85. PubMed ID: 12007944
[TBL] [Abstract][Full Text] [Related]
2. Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma.
Lee AW; Foo W; Chappell R; Fowler JF; Sze WM; Poon YF; Law SC; Ng SH; O SK; Tung SY; Lau WH; Ho JH
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):35-42. PubMed ID: 9422555
[TBL] [Abstract][Full Text] [Related]
3. Different risks of symptomatic brain necrosis in NPC patients treated with different altered fractionated radiotherapy techniques.
Jen YM; Hsu WL; Chen CY; Hwang JM; Chang LP; Lin YS; Su WF; Chen CM; Liu DW; Chao HL
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):344-8. PubMed ID: 11567807
[TBL] [Abstract][Full Text] [Related]
4. Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors.
Lee AW; Ng WT; Hung WM; Choi CW; Tung R; Ling YH; Cheng PT; Yau TK; Chang AT; Leung SK; Lee MC; Bentzen SM
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1121-8. PubMed ID: 18723296
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
[TBL] [Abstract][Full Text] [Related]
6. Reirradiation for recurrent nasopharyngeal carcinoma: factors affecting the therapeutic ratio and ways for improvement.
Lee AW; Foo W; Law SC; Poon YF; Sze WM; O SK; Tung SY; Lau WH
Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):43-52. PubMed ID: 9212003
[TBL] [Abstract][Full Text] [Related]
7. Caution on the use of altered fractionation for nasopharyngeal carcinoma.
Lee AW; Sze WM; Fowler JF; Chappell R; Leung SF; Teo P
Radiother Oncol; 1999 Sep; 52(3):207-11. PubMed ID: 10580865
[TBL] [Abstract][Full Text] [Related]
8. Effect of dosimetric factors on occurrence and volume of temporal lobe necrosis following intensity modulated radiation therapy for nasopharyngeal carcinoma: a case-control study.
Zhou X; Ou X; Xu T; Wang X; Shen C; Ding J; Hu C
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):261-9. PubMed ID: 25066214
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation.
Kam MK; Chau RM; Suen J; Choi PH; Teo PM
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):145-57. PubMed ID: 12694833
[TBL] [Abstract][Full Text] [Related]
10. Clinical radiobiology of stage T2-T3 bladder cancer.
Majewski W; Maciejewski B; Majewski S; Suwinski R; Miszczyk L; Tarnawski R
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):60-70. PubMed ID: 15337540
[TBL] [Abstract][Full Text] [Related]
11. Dose-volume relationships associated with temporal lobe radiation necrosis after skull base proton beam therapy.
McDonald MW; Linton OR; Calley CS
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):261-7. PubMed ID: 25636754
[TBL] [Abstract][Full Text] [Related]
12. How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?
Teo PM; Kwan WH; Chan AT; Lee WY; King WW; Mok CO
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):897-913. PubMed ID: 9531376
[TBL] [Abstract][Full Text] [Related]
13. Clinical diagnosis of late temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma.
Lee AW; Ng SH; Ho JH; Tse VK; Poon YF; Tse CC; Au GK; O SK; Lau WH; Foo WW
Cancer; 1988 Apr; 61(8):1535-42. PubMed ID: 3349419
[TBL] [Abstract][Full Text] [Related]
14. Dose escalation using twice-daily radiotherapy for nasopharyngeal carcinoma: does heavier dosing result in a happier ending?
Jen YM; Lin YS; Su WF; Hsu WL; Hwang JM; Chao HL; Liu DW; Chen CM; Lin HY; Wu CJ; Chang LP; Shueng PW
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):14-22. PubMed ID: 12182970
[TBL] [Abstract][Full Text] [Related]
15. Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma.
Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; Wong CS; O SK
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1331-8. PubMed ID: 11121630
[TBL] [Abstract][Full Text] [Related]
16. Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma.
Hara W; Loo BW; Goffinet DR; Chang SD; Adler JR; Pinto HA; Fee WE; Kaplan MJ; Fischbein NJ; Le QT
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):393-400. PubMed ID: 18164839
[TBL] [Abstract][Full Text] [Related]
17. Temporal lobe toxicity analysis after proton radiation therapy for skull base tumors.
Pehlivan B; Ares C; Lomax AJ; Stadelmann O; Goitein G; Timmermann B; Schneider RA; Hug EB
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1432-40. PubMed ID: 22349042
[TBL] [Abstract][Full Text] [Related]
18. Fractionated stereotactic radiotherapy with vagina carotica protection technique for local residual nasopharyngeal carcinoma after primary radiotherapy.
Liu F; Xiao JP; Xu YJ; Zhang Y; Xu GZ; Gao L; Yi JL; Luo JW; Huang XD; Huan FK; Fang H; Wan B; Li YX
Chin Med J (Engl); 2012 Jul; 125(14):2525-9. PubMed ID: 22882934
[TBL] [Abstract][Full Text] [Related]
19. Brain abscess formation in radiation necrosis of the temporal lobe following radiation therapy for nasopharyngeal carcinoma.
Cheng KM; Chan CM; Fu YT; Ho LC; Tsang YW; Lee MK; Cheung YL; Law CK
Acta Neurochir (Wien); 2000; 142(4):435-40; discussion 440-1. PubMed ID: 10883341
[TBL] [Abstract][Full Text] [Related]
20. [Brain radionecrosis in patients irradiated for nasopharyngeal carcinoma: about nine cases].
Nasr Ben Ammar C; Chaari N; Kochbati L; Attia I; Ben Hamadi D; Chebbi A; Saadi A; Besbes M; Maalej M
Cancer Radiother; 2007 Sep; 11(5):234-40. PubMed ID: 17631405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
